Cargando…

Multimodal treatment options for bilobar colorectal liver metastases

PURPOSE: We evaluated individualized multimodal oncological strategies in patients with bilobular colorectal liver metastases (biCRC-LM) as well as their effect on R0 resection rates, disease-free survival (DFS), and overall survival (OS). METHODS: Between January 2001 and December 2008, 64 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Homayounfar, Kia, Liersch, Torsten, Niessner, Martin, Meller, Johannes, Lorf, Thomas, Becker, Heinz, Ghadimi, B. Michael
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908753/ https://www.ncbi.nlm.nih.gov/pubmed/20213463 http://dx.doi.org/10.1007/s00423-010-0604-7

Ejemplares similares

Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment
por: Homayounfar, K., et al.
Publicado: (2012)

Two-stage hepatectomy (R0) with portal vein ligation—towards curing patients with extended bilobular colorectal liver metastases
por: Homayounfar, K., et al.
Publicado: (2008)

Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival
por: Homayounfar, K., et al.
Publicado: (2013)

Resection margin influences the outcome of patients with bilobar colorectal liver metastases
por: Di Carlo, Sara, et al.
Publicado: (2016)

Simultaneous curative resection of double colorectal carcinoma with synchronous bilobar liver metastases
por: De Raffele, Emilio, et al.
Publicado: (2018)

Preoperative Chemoradiotherapy Does Not Necessarily Reduce Lymph Node Retrieval in Rectal Cancer Specimens—Results from a Prospective Evaluation with Extensive Pathological Work-up
por: Sprenger, Thilo, et al.
Publicado: (2009)

Solitary extrapleural fibrous tumor with hepatic bilobar metastases: multimodal approach treatment
por: Orue-Echebarria, Maitane I., et al.
Publicado: (2020)

HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer
por: Styczen, Hanna, et al.
Publicado: (2015)

Distinct Chromosomal Profiles in Metastasizing and Non-Metastasizing Colorectal Carcinomas
por: Ghadimi, B. Michael, et al.
Publicado: (2006)

Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer
por: Spelt, Lidewij, et al.
Publicado: (2018)

Technique of vessel-skeletonized parenchyma-sparing hepatectomy for the oncological treatment of bilobar colorectal liver metastases
por: Umeda, Yuzo, et al.
Publicado: (2021)

Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment
por: Conradi, Lena-Christin, et al.
Publicado: (2011)

Parenchymal-sparing hepatectomy for multiple bilobar colorectal liver metastases in a Jehovah’s witness: a case report
por: Ratnayake, Shehan, et al.
Publicado: (2023)

A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature
por: Ramírez-Plaza, César P., et al.
Publicado: (2015)

Molecular Cytogenetics: Genomic Imbalances in Colorectal Cancer and their Clinical Impact
por: Grade, Marian, et al.
Publicado: (2006)

Development and validation of a novel risk score to predict overall survival following surgical clearance of bilobar colorectal liver metastases
por: Dasari, Bobby V M, et al.
Publicado: (2023)

Parenchyma sparing multicomponent liver resection strategy for multiple bilobar synchronous colorectal cancer metastasis
por: Burlaka, Anton Anatoliyovych, et al.
Publicado: (2020)

Spontaneous bilobar torsion managed with pneumopexy
por: Qaqish, T. Robert, et al.
Publicado: (2021)

Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases
por: Haas, Gwendolyn, et al.
Publicado: (2021)

β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases
por: Bleckmann, Annalen, et al.
Publicado: (2016)

The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
por: Rühlmann, Felix, et al.
Publicado: (2017)

Surgical Options for Initially Unresectable Colorectal Liver Metastases
por: Popescu, Irinel, et al.
Publicado: (2012)

Bilobar congenital lobar emphysema in a child: how to approach it?
por: Govindarajan, Krishna Kumar
Publicado: (2021)

Commentary: Bilobar lung torsion—Time is parenchyma in race to treatment
por: Chen, Lin, et al.
Publicado: (2021)

Pulmonary venous thrombosis of traumatic origin as cause of bilobar infarction()
por: Ortega, Astrid Carolina Alvarez, et al.
Publicado: (2023)

The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancer
por: Lowes, Markus, et al.
Publicado: (2017)

I BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES
por: COIMBRA, Felipe José Fernandez, et al.
Publicado: (2015)

A 77 year old man with gangrenous cholecystitis and incidental findings of multiple bilobar liver lipomatosis
por: Coco, Danilo, et al.
Publicado: (2020)

The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases
por: Line, Pål-Dag, et al.
Publicado: (2018)

Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases
por: Abdel-Rahman, Omar, et al.
Publicado: (2018)

BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES
por: TORRES, Orlando Jorge Martins, et al.
Publicado: (2016)

High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases
por: Strowitzki, Moritz J., et al.
Publicado: (2019)

I BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 2: APPROACH TO RESECTABLE METASTASES
por: RIBEIRO, Héber Salvador de Castro, et al.
Publicado: (2016)

Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?
por: Sprenger, Thilo, et al.
Publicado: (2010)

Unilobar Versus Bilobar Biliary Drainage: Effect on Quality of Life and Bilirubin Level Reduction
por: Gamanagatti, Shivanand, et al.
Publicado: (2016)

Multidisciplinary approach for multifocal, bilobar hepatocellular carcinoma: A case report and literature review
por: Labadie, Kevin P, et al.
Publicado: (2019)

Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab
por: Jeschke, Matthias, et al.
Publicado: (2023)

THU665 Unilateral Graves’ Disease In A Bilobar Thyroid Gland: Unusual Cause Of Hyperthyroidism
por: Hamid Alaybaa, Khaled, et al.
Publicado: (2023)

Unilateral Graves’ Disease in a Bilobar Thyroid Gland: A Very Unusual Cause of Hyperthyroidism
por: Alaybaa, Khaled, et al.
Publicado: (2023)

Resectability of bilobar liver tumours after simultaneous portal and hepatic vein embolization versus portal vein embolization alone: meta-analysis
por: Korenblik, Remon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fprh394eopi1v1fbq4il7foiel